CR

CREEK & RIVER Co.,Ltd.

A creator agency connecting professionals in creative, tech, medical, and legal sectors.

4763 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区新橋四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CREEK & RIVER Co., Ltd. is a multifaceted professional agency that pioneered the "creator agency" business model in Japan. The company specializes in connecting its extensive network of skilled professionals with businesses across various industries for staffing, outsourcing, and consulting projects. While its origins and strengths lie in creative fields—including video, games, web, and advertising—the firm has expanded its services to encompass a diverse range of professional sectors such as medicine, law, accounting, architecture, and advanced technology like AI and XR. In addition to its core agency business, CREEK & RIVER provides content production and rights management services, leveraging its diverse talent pool to drive innovation for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-02 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-05-30 08:22
Post-Annual General Meeting Information
臨時報告書
Japanese 26.5 KB
2025-05-30 08:21
Governance Information
内部統制報告書-第35期(2024/03/01-2025/02/28)
Japanese 22.4 KB
2025-05-30 08:20
Registration Form
確認書
Japanese 8.2 KB
2025-05-30 08:19
Annual Report
有価証券報告書-第35期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-05-01 09:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-04-01 09:27
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-03-21 07:58
Regulatory News Service
臨時報告書
Japanese 28.6 KB
2025-03-04 03:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-02-03 07:47
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 20.9 KB
2024-12-02 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2024-11-06 01:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.1 KB
2024-10-11 03:52
Interim Report
半期報告書-第35期(2024/03/01-2025/02/28)
Japanese 254.6 KB
2024-10-11 03:52
Regulatory News Service
確認書
Japanese 8.1 KB
2024-10-01 04:39
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.1 KB

Automate Your Workflow. Get a real-time feed of all CREEK & RIVER Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CREEK & RIVER Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.